ER+ BREAST CANCER

Clinical trials for ER+ BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new ER+ BREAST CANCER trials appear

Sign up with your email to follow new studies for ER+ BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 4

Breast cancer pill study: do patients stick with it?

Knowledge-focused Not yet recruiting

This study tracks 81 patients with early-stage, hormone-positive breast cancer who are prescribed a two- to three-year course of CDK4/6 inhibitor pills (abemaciclib or ribociclib) after surgery. The goal is to see how many stop taking the pills early and why. Researchers hope to …

Matched conditions: ER+ BREAST CANCER

Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused

Last updated May 11, 2026 20:39 UTC

ER+ BREAST CANCER

Get alerted when new ER+ BREAST CANCER trials appear

Breast cancer pill study: do patients stick with it?